On 29 April 2015 was held in Dakar, Senegal, a seminar on counterfeit medicines called “Integrated approach against fake medicines”. Organized by the fondation Chirac and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), in partnership with Innovate Develop Advance (DIA), international experts of counterfeit medicines were concerned about the increasing number of deaths linked to drugs counterfeit in Africa.
According to articles published on April 20th, 2015 in the American Journal of Tropical Medicine and Hygiene (AJTMH), poor quality drugs and fake antimalarial result in ineffective treatments against malaria. The main target of traffickers being Africa. The death of 122,350 African children in 2013 was announced due to a fake antimalarial and a substandard drug.
On the African continent, this counterfeiting is estimated at 30%. This percentage is much higher in some countries of this area. The high price of drugs, porous borders, absence of laboratory controls, inadequate regulations, little dissuasive sentences (from 6 days to 6 months in prison in Senegal), and few rural pharmacies, so many reasons that make Africa the most-at-risk continent.
Africa produces less than 5% of these counterfeit drugs, the majority are coming from India and China. These countries must play a key role in preventing these drugs to enter in Africa.
Professor Marc Gentilini, General Delegate of the fondation Chirac for access to health and quality drugs, recalled that “eradicate the scourge of fake drugs cannot be done alone. But it requires accountability of decision-makers who have to mobilize resources to increase cooperation and harmonization, both national and international. ”
We strongly support the efforts of our partners in this fight to eradicate counterfeit drugs in Africa.
Sources: fondation Chirac, IFPMA, Fight the FakesBack to previous